Structure and Biomedical Applications of Amyloid Oligomer Nanoparticles
Kumar et al., ACS nano (2014) - PMID: 25337989
Product(s) used in this publication: Amyloid Beta A4 Peptides
Amyloid oligomers are nonfibrillar polypeptide aggregates linked to diseases, such as Alzheimer's and Parkinson's. Here we show that these aggregates possess a compact, quasi-crystalline architecture that presents significant nanoscale regularity. The amyloid oligomers are dynamic assemblies and are able to release their individual subunits. The small oligomeric size and spheroid shape confer diffusible characteristics, electrophoretic mobility, and the ability to enter hydrated gel matrices or cells. We finally showed that the amyloid oligomers can be labeled with both fluorescence agents and iron oxide nanoparticles and can target macrophage cells. Oligomer amyloids may provide a new biological nanomaterial for improved targeting, drug release, and medical imaging.
cell penetration; delivery systems; neurodegeneration; peptide assembly; protein misfolding